Orlando Health Ventures
Late Stage
What they invest in
from 1 of 1 portfolio companiesHardware Γ1Healthtech Γ1Medical Devices Γ1
HQs:United StatesΓ1
Investments Β· 1 tracked
founders shown can be your intro path
Sensydia develops the Cardiac Performance System (CPS), a non-invasive, automated platform that uses disposable sensors to measure advanced hemodynamic metrics such as ejection fraction, cardiac output, and pulmonary artery pressure.
HardwareHealthtechMedical DevicesLos Angeles, US
BoardG. Bradford Jones(Director)William Kaiser(Executive Officer)inVictoria K. Grace(Director)inAman Mahajan(Executive Officer, Director)Thomas Bruggere(Executive Officer, Director)
Co-investorsColle Capital PartnersFrontier Venture Capital
Portfolio news
latest coverage across their companiesSensydia Β· sensydia.com Β· Jun 10, 2025
Frequently asked questions
- What stage does Orlando Health Ventures invest at?
- Orlando Health Ventures invests at the Late Stage stage.
Similar investors
3TS Capital Partners is a private equity and venture capital investor focused on technology and technology-enabled companies, notably in Central and Eastern Europe.
83North is a global venture capital firm that invests in and helps entrepreneurs build large, category-defining companies, backing startups across multiple stages and sectors.
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
Accel is a venture capital firm that partners with exceptional teams, positioning itself as a first partner to founders globally.